Gavi’s Shots for All Plan

One of the biggest questions around an eventual COVID-19 vaccine: Will it be equitably deployed throughout the world?
Inspired by previous efforts around Ebola and pneumococcal vaccines,
Gavi, the Vaccine Alliance has launched a $2 billion funding mechanism aimed at ensuring a COVID-19 vaccine reaches the most vulnerable.  
The plan—which is only the first step in a larger effort—incentivizes drug makers to ramp up production capacity by offering volume guarantees before candidates are licensed, which would speed up deployment when the vaccine arrives.
World leaders are getting behind the push, more aware than ever that global vaccine collaboration will be key to ending the pandemic, Quartz reports.
And with rising vaccine skepticism, communication will be key to convincing the public that a super-expedited approval process didn’t skimp on safety, CNN reports.

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top